|
|
| Phases of Development | Preclinical | Phase I | Phase I/II | Phase II | Pivotal | Phase III | Registration | Marketed |
|---|
| Autoimmune | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | | Cancer | 5 | 14 | 4 | 10 | 1 | 2 | 1 | 2 | | Diagnostic | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | Endocrine / Metabolic | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | Hematology | 0 | 1 | 0 | 2 | 0 | 0 | 0 | 0 | | Infectious | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | | Inflammation | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | Neurology | 0 | 2 | 0 | 1 | 0 | 0 | 0 | 0 | | Transplant | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
|
|
Products Targeting Histone deacetylase (HDAC)